本則回應

• Ann標記此篇為：💬 含有個人意見

  理由

  1. 影片中提及的研究，確實刊登於《神經病學雜誌（Journal of Neurology）》第269卷第3期。但這些病例為接種疫苗後的「不良事件」，代表尚不確定是否和疫苗有關，研究也沒有暗示接種疫苗後會面臨長期風險增加。
  
  2. 另根據國際期刊《美國醫學會期刊》研究，130位多發性
  
  閱讀更多

  不同意見

  「多發性硬化症患者接種第三劑新冠疫苗的安全性研究」專家意見
  https://health-desk.org/articles/duo-fa-⋯e-an-quan-xing-yan-jiu-zhuan-jia-yi-jian
  
  台灣神經免疫學會《MS患者與COVID-19疫苗》
  https://www.tnms.com.tw/msandcovid-19/
  
  A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines
  https://www.frontiersin.org/articles/10.3389/fneur.2022.796882/full
  
  COVID-19 mRNA vaccination leading to CNS inflammation: a case series
  https://pubmed.ncbi.nlm.nih.gov/34480607/

  「多發性硬化症患者接種第三劑新冠疫苗的安全性研究」專家意見

  https://health-desk.org/articles/duo-fa-xing-ying-hua-zheng-huan-zhe-jie-zhong-di-san-ji-xin-guan-yi-miao-de-an-quan-xing-yan-jiu-zhuan-jia-yi-jian

  Jan 25, 2022 by Science Media Center Taiwan – 議題背景：今（2021）年1月25日，國際期刊《美國醫學會期刊》網路開放版（JAMA Network Open）發表一篇研究。研究指出，已接種過兩劑BNT或莫德納疫苗的130位多發性硬化症患者，再接種第三劑mRNA疫苗後，有病毒棘蛋白專一性的抗體效價增加，且沒有患者產生嚴重的不良反應，最多是注射處疼痛和感到

  https://www.tnms.com.tw/msandcovid-19/

  Cannot get data from URL

  A Single-Health System Case Series of New-Onset CNS Inflammatory Disorders Temporally Associated With mRNA-Based SARS-CoV-2 Vaccines

  https://www.frontiersin.org/articles/10.3389/fneur.2022.796882/full

  BackgroundSince 2020, over 250 million doses of mRNA-based SARS-CoV-2 vaccines have been administered in the United States and hundreds of millions worldwide between the Pfizer-BioNTech and Moderna SA

  COVID-19 mRNA vaccination leading to CNS inflammation: a case series - PubMed

  https://pubmed.ncbi.nlm.nih.gov/34480607/

  The availability of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID-19) pandemic. Vaccine saf